Crenezumab, CAS 1095207-05-8

Product Description: Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research[1].

Applications: Neuroscience-Neurodegeneration

Formula: N/A

References: [1]S Zampar, et al. N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer's disease. Neuropathol Appl Neurobiol. 2020 Dec;46(7):673-685.

CAS Number: 1095207-05-8

Molecular Weight: N/A

Compound Purity: 97.27

Research Area: Neurological Disease

Solubility: 10 mM in DMSO

Target: Amyloid-β

• Artikelnummer: MEXHY-P99835-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99835-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated